Healthcare AI Spending Shifts to Patient Care, Drug Discovery

A new report from Menlo Ventures reveals that AI spending in healthcare is shifting from administrative tasks to areas like drug discovery, clinical decision-making, and patient care. The 2026: State of AI in Healthcare report highlights that healthcare remains AI’s largest market, with spending reaching $3.7 billion, outpacing legal and finance combined. This growth, at 2.5 times the previous year, is more than double the next-largest vertical, legal, which stands at $1.8 billion.
Healthcare AI Spending Outpaces Other Industries
The study surveyed 550 U.S. healthcare executives, including 150 technology decision-makers at provider organizations, 100 senior executives at health plans and benefits administrators, and 300 executives at pharmaceutical and biotech companies developing their own therapeutics.
The provider market is experiencing rapid changes, with established companies gaining ground. In the AI scribe market, incumbents now hold 46% of the $950 million market, up from 33% last year, capturing 68% of new scribe dollars. Meanwhile, AI-native scribes, though growing 28%, have lost market share but are expanding into new areas like prior authorization, which is now their top AI priority at 82%, up from 59%.
AI Innovation Moves Closer to Patient Care
The report highlights the growth of clinical copilots and patient engagement AI, which grew 5.5x to $550 million and 4.5x to $450 million, respectively. In contrast, AI scribes and coding/billing AI grew at slower rates of 1.6x and 1.3x. This shift indicates a move towards patient-centric AI solutions.
Life Sciences AI Spending Surges
Payers are increasingly funding providers’ AI initiatives, with external AI spending reaching $150 million. However, 43% of payers report that provider AI coding has raised their medical cost trend in 2026, up from 23% in 2025. As a result, prior authorization has become their top AI priority.
The most significant growth is in life sciences AI spending, which surged 23x from $30 million to $700 million, the fastest growth of any healthcare AI segment. Greg Yap, venture partner at Menlo Ventures, attributes this growth to the potential of AI agents and frontier models to improve health outcomes and lower costs. As AI continues to evolve, its impact on healthcare is expected to deepen, driving further investment and innovation.